American Portfolios Advisors Intercept Pharmaceuticals, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Intercept Pharmaceuticals, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 31,000 shares of ICPT stock, worth $0. This represents 0.02% of its overall portfolio holdings.

Number of Shares
31,000
Holding current value
$0
% of portfolio
0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$12.21 - $19.7 $378,510 - $610,700
31,000 New
31,000 $432 Million
Q2 2022

Mar 20, 2023
BUY
$11.23 - $19.59 $393 - $685
35 Added 0.11%
31,035 $429 Million
Q1 2022

Mar 21, 2023
BUY
$13.37 - $17.79 $2,607 - $3,469
195 Added 0.63%
31,195 $508 Million
Q4 2021

Mar 21, 2023
BUY
$14.28 - $19.53 $2,070 - $2,831
145 Added 0.47%
31,145 $507 Million
Q3 2021

Mar 22, 2023
BUY
$12.99 - $20.47 $1,883 - $2,968
145 Added 0.47%
31,145 $463 Million
Q2 2021

Mar 22, 2023
BUY
$15.46 - $24.5 $3,014 - $4,777
195 Added 0.63%
31,195 $623 Million
Q1 2021

Mar 22, 2023
BUY
$19.33 - $37.75 $3,962 - $7,738
205 Added 0.66%
31,205 $720 Million
Q4 2020

Mar 22, 2023
SELL
$24.48 - $42.47 $509,061 - $883,163
-20,795 Reduced 67.08%
10,205 $252 Million
Q3 2020

Mar 22, 2023
SELL
$39.09 - $53.44 $769,877 - $1.05 Million
-19,695 Reduced 63.53%
11,305 $469 Million
Q2 2020

Mar 24, 2023
BUY
$46.7 - $92.04 $12,842 - $25,311
275 Added 2.48%
11,380 $545 Million
Q1 2020

Mar 24, 2023
SELL
$48.35 - $118.68 $961,923 - $2.36 Million
-19,895 Reduced 64.18%
11,105 $699 Million
Q4 2019

Mar 24, 2023
SELL
$57.36 - $124.1 $1.1 Million - $2.37 Million
-19,097 Reduced 61.6%
11,903 $1.48 Billion
Q2 2019

Mar 24, 2023
SELL
$77.77 - $120.68 $1.54 Million - $2.39 Million
-19,845 Reduced 64.02%
11,155 $888 Million
Q4 2018

Mar 24, 2023
SELL
$85.79 - $126.46 $5,147 - $7,587
-60 Reduced 36.36%
105 $10.6 Million
Q3 2018

Mar 24, 2023
SELL
$88.49 - $127.55 $2.73 Million - $3.93 Million
-30,835 Reduced 99.47%
165 $20.8 Million
Q2 2018

Mar 24, 2023
BUY
$60.0 - $85.67 $88,500 - $126,363
1,475 Added 270.64%
2,020 $169 Million
Q1 2018

Mar 24, 2023
SELL
$52.72 - $67.25 $1.61 Million - $2.05 Million
-30,455 Reduced 98.24%
545 $33.5 Million
Q4 2017

Mar 24, 2023
SELL
$58.2 - $72.76 $1.77 Million - $2.21 Million
-30,415
585 $34.2 Million

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email